(Docaravimab)Biosimilar Reference Antibody-GS40187主打

货号：GS40187

Docaravimab is a monoclonal antibody (mAb) that forms part of the world's first fully monoclonal antibody cocktail for rabies post-exposure prophylaxis (PEP). It is designed as a safe and effective alternative to traditional rabies immunoglobulin (RIG), which is derived from human or equine blood. By directly neutralizing the rabies virus at the site of exposure before it can reach the central nervous system, offers a standardized, non-blood-derived, and potentially more accessible option for preventing rabies after a suspected exposure.